CVS Health Corporation (CVS) Shares Bought by Fiduciary Trust Co.

Fiduciary Trust Co. raised its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 366,007 shares of the pharmacy operator’s stock after buying an additional 4,265 shares during the quarter. CVS Health Corporation comprises 0.9% of Fiduciary Trust Co.’s investment portfolio, making the stock its 25th largest holding. Fiduciary Trust Co.’s holdings in CVS Health Corporation were worth $28,732,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Naples Global Advisors LLC acquired a new position in shares of CVS Health Corporation during the first quarter worth approximately $452,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of CVS Health Corporation by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after buying an additional 5,478 shares during the last quarter. Candriam Luxembourg S.C.A. lifted its holdings in shares of CVS Health Corporation by 17.9% during the first quarter. Candriam Luxembourg S.C.A. now owns 92,139 shares of the pharmacy operator’s stock worth $7,233,000 after buying an additional 14,012 shares during the last quarter. British Columbia Investment Management Corp lifted its holdings in shares of CVS Health Corporation by 3.7% during the first quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock worth $44,062,000 after buying an additional 19,794 shares during the last quarter. Finally, Northern Capital Management LLC lifted its holdings in shares of CVS Health Corporation by 15.5% during the first quarter. Northern Capital Management LLC now owns 43,455 shares of the pharmacy operator’s stock worth $3,411,000 after buying an additional 5,830 shares during the last quarter. Institutional investors own 81.55% of the company’s stock.

CVS has been the subject of a number of research analyst reports. Jefferies Group LLC reiterated a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, June 9th. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 price target for the company in a report on Wednesday, May 24th. Cowen and Company reiterated an “outperform” rating and set a $86.00 price target on shares of CVS Health Corporation in a report on Tuesday, June 13th. ValuEngine lowered CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Leerink Swann set a $90.00 price target on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the stock. CVS Health Corporation presently has a consensus rating of “Buy” and an average price target of $90.83.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.86% during mid-day trading on Friday, reaching $79.72. The company’s stock had a trading volume of 4,252,922 shares. The firm has a 50 day moving average price of $78.33 and a 200 day moving average price of $78.92. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $92.26. The firm has a market cap of $81.04 billion, a price-to-earnings ratio of 15.88 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same quarter last year, the company earned $1.32 EPS. The company’s revenue was up 4.5% on a year-over-year basis. On average, equities analysts predict that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares in the company, valued at approximately $4,564,914. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the transaction, the chief financial officer now owns 176,983 shares in the company, valued at approximately $14,158,640. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 273,675 shares of company stock worth $21,831,647. Corporate insiders own 0.61% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corporation (CVS) Shares Bought by Fiduciary Trust Co.” was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.themarketsdaily.com/2017/09/10/cvs-health-corporation-cvs-shares-bought-by-fiduciary-trust-co.html.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply